Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Protein Sci ; 4(12): 2578-86, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8580849

RESUMO

Of the major amino acid side chains that anchor pyridoxal 5'-phosphate at the coenzyme binding site of bacterial D-amino acid transaminase, two have been substituted using site-directed mutagenesis. Thus, Ser-180 was changed to an Ala (S180A) with little effect on enzyme activity, but replacement of Tyr-31 by Gln (Y31Q) led to 99% loss of activity. Titration of SH groups of the native Y31Q enzyme with DTNB proceeded much faster and to a greater extent than the corresponding titration for the native wild-type and S180A mutant enzymes. The stability of each mutant to denaturing agents such as urea or guanidine was similar, i.e., in their PLP forms, S180A and Y31Q lost 50% of their activities at a 5-15% lower concentration of urea or guanidine than did the wild-type enzyme. Upon removal of denaturing agent, significant activity was restored in the absence of added pyridoxal 5'-phosphate, but addition of thiols was required. In spite of its low activity, Y31Q was able to form the PMP form of the enzyme just as readily as the wild-type and the S180A enzymes in the presence of normal D-amino acid substrates. However, beta-chloro-D-alanine was a much better substrate and inactivator of the Y31Q enzyme than it was for the wild-type or S180A enzymes, most likely because the Y31Q mutant formed the pyridoxamine 5-phosphate form more rapidly than the other two enzymes. The stereochemical fidelity of the Y31Q recombinant mutant enzyme was much less than that of the S180A and wild-type enzymes because racemase activity, i.e., conversion of L-alanine to D-alanine, was higher than for the wild-type or S180A mutant enzymes, perhaps because the coenzyme has more flexibility in this mutant enzyme.


Assuntos
Fosfato de Piridoxal/metabolismo , Transaminases/química , Transaminases/metabolismo , Alanina/metabolismo , Sequência de Bases , Sítios de Ligação , Catálise , D-Alanina Transaminase , Inibidores Enzimáticos/farmacologia , Estabilidade Enzimática , Guanidina , Guanidinas , Temperatura Alta , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Desnaturação Proteica , Proteínas Recombinantes , Espectrofotometria , Relação Estrutura-Atividade , Especificidade por Substrato , Compostos de Sulfidrila/análise , Transaminases/genética , Ureia , beta-Alanina/análogos & derivados , beta-Alanina/farmacologia
2.
Biochemistry ; 32(27): 7030-4, 1993 Jul 13.
Artigo em Inglês | MEDLINE | ID: mdl-8334133

RESUMO

The calcium-transporting ATPase of sarcoplasmic reticulum is known to bind two Ca2+ ions from the cytoplasm to the free enzyme and two Ca2+ ions from the lumen to the phosphoenzyme. The concentration of phosphoenzyme formed at equilibrium from Pi and Mg2+ increases with increasing concentration of calcium in the lumen, which binds to the phosphoenzyme to form Ca2.E approximately P.Mg. However, at subsaturating concentrations of Mg2+ increasing the concentration of lumenal Ca2+ does not drive phosphoenzyme formation to completion. The maximal levels of phosphoenzyme that are formed at saturating concentrations of lumenal Ca2+ increase with increasing concentrations of Mg2+. This result requires that Ca2+ can bind to low-affinity lumenal sites on both the free enzyme and the phosphoenzyme, as well as to the high-affinity cytoplasmic calcium-binding sites. If there were no lumenal binding sites for Ca2+ on the free enzyme, high concentrations of lumenal Ca2+ would convert all of the enzyme to the same maximal concentration of Ca2.E approximately P.Mg at subsaturating concentrations of Mg2+ and Pi. We conclude that there are two low-affinity lumenal sites as well as two high-affinity cytoplasmic sites for Ca2+ on the free enzyme. Phosphorylation by ATP results in translocation of Ca2+ from the high-affinity to the low-affinity sites.


Assuntos
ATPases Transportadoras de Cálcio/metabolismo , Cálcio/metabolismo , Retículo Sarcoplasmático/enzimologia , Animais , Sítios de Ligação , Magnésio/metabolismo , Coelhos
3.
Biochemistry ; 37(14): 4958-67, 1998 Apr 07.
Artigo em Inglês | MEDLINE | ID: mdl-9538014

RESUMO

The three-dimensional structures of two forms of the D-amino acid aminotransferase (D-aAT) from Bacillus sp. YM-1 have been determined crystallographically: the pyridoxal phosphate (PLP) form and a complex with the reduced analogue of the external aldimine, N-(5'-phosphopyridoxyl)-d-alanine (PPDA). Together with the previously reported pyridoxamine phosphate form of the enzyme [Sugio et al. (1995) Biochemistry 34, 9661], these structures allow us to describe the pathway of the enzymatic reaction in structural terms. A major determinant of the enzyme's stereospecificity for D-amino acids is a group of three residues (Tyr30, Arg98, and His100, with the latter two contributed by the neighboring subunit) forming four hydrogen bonds to the substrate alpha-carboxyl group. The replacement by hydrophobic groups of the homologous residues of the branched chain L-amino acid aminotransferase (which has a similar fold) could explain its opposite stereospecificity. As in L-aspartate aminotransferase (L-AspAT), the cofactor in D-aAT tilts (around its phosphate group and N1 as pivots) away from the catalytic lysine 145 and the protein face in the course of the reaction. Unlike L-AspAT, D-aAT shows no other significant conformational changes during the reaction.


Assuntos
Alanina Transaminase/metabolismo , Alanina Transaminase/química , Bacillus/enzimologia , Sítios de Ligação , Catálise , Cristalografia por Raios X , D-Alanina Transaminase , Compostos de Diazônio/química , Compostos de Diazônio/metabolismo , Estrutura Molecular , Piridinas/química , Piridinas/metabolismo , Fosfato de Piridoxal/química , Fosfato de Piridoxal/metabolismo , Piridoxamina/análogos & derivados , Piridoxamina/química , Piridoxamina/metabolismo , Especificidade por Substrato
4.
Protein Eng ; 11(8): 613-9, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9749913

RESUMO

The leucine-to-alanine mutation at residue 201 of D-amino acid aminotransferase provides a unique enzyme which gradually loses its activity while catalyzing the normal transamination; the co-enzyme form is converted from pyridoxal 5'-phosphate to pyridoxamine 5'-phosphate upon the inactivation [Kishimoto,K., Yoshimura,T., Esaki,N., Sugio,S., Manning,J.M. and Soda,K. (1995) J. Biochem., 117, 691-696]. Crystal structures of both co-enzyme forms of the mutant enzyme have been determined at 2.0 A resolution: they are virtually identical, and are quite similar to that of the wild-type enzyme. Significant differences in both forms of the mutant are localized only on the bound co-enzyme, the side chains of Lys145 and Tyr31, and a water molecule sitting on the putative substrate binding site. Detailed comparisons of the structures of the mutant, together with that of the pyridoxamine-5'-phosphate form of the wild-type enzyme, imply that Leu201 would play a crucial role in the transamination reaction by keeping the pyridoxyl ring in the proper location without disturbing its oscillating motion, although the residue seems to not be especially important for the structural integrity of the enzyme.


Assuntos
Alanina Transaminase/química , Alanina Transaminase/genética , Mutação , Alanina/metabolismo , Alanina Transaminase/metabolismo , Sítios de Ligação , Cristalografia por Raios X , D-Alanina Transaminase , Ativação Enzimática , Ácidos Cetoglutáricos/metabolismo , Leucina , Modelos Moleculares , Conformação Proteica
5.
Nat Struct Biol ; 4(3): 231-8, 1997 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-9164465

RESUMO

Histidine triad nucleotide-binding protein (HINT), a dimeric purine nucleotide-binding protein from rabbit heart, is a member of the HIT (histidine triad) superfamily which includes HINT homologues and FHIT (HIT protein encoded at the chromosome 3 fragile site) homologues. Crystal structures of HINT-nucleotide complexes demonstrate that the most conserved residues in the superfamily mediate nucleotide binding and that the HIT motif forms part of the phosphate binding loop. Galactose-1-phosphate uridylyltransferase, whose deficiency causes galactosemia, contains tandem HINT domains with the same fold and mode of nucleotide binding as HINT despite having no overall sequence similarity. Features of FHIT, a diadenosine polyphosphate hydrolase and candidate tumour suppressor, are predicted from HINT-nucleotide structures.


Assuntos
Hidrolases , Modelos Estruturais , Estrutura Secundária de Proteína , Proteínas/química , UTP-Hexose-1-Fosfato Uridililtransferase/química , Sequência de Aminoácidos , Animais , Sítios de Ligação , Evolução Biológica , Mapeamento Cromossômico , Simulação por Computador , Cristalografia por Raios X , Dimerização , Histidina , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Miocárdio/metabolismo , Nucleosídeos/metabolismo , Nucleotídeos/metabolismo , Proteínas/genética , Proteínas/metabolismo , Coelhos , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Homologia de Sequência de Aminoácidos , Software , UTP-Hexose-1-Fosfato Uridililtransferase/metabolismo
6.
Biochemistry ; 38(4): 1323-31, 1999 Jan 26.
Artigo em Inglês | MEDLINE | ID: mdl-9930994

RESUMO

D-Amino acid transaminase is a bacterial enzyme that uses pyridoxal phosphate (PLP) as a cofactor to catalyze the conversion of D-amino acids into their corresponding alpha-keto acids. This enzyme has already been established as a target for novel antibacterial agents through suicide inactivation by a number of compounds. To improve their potency and specificity, the detailed enzyme mechanism, especially the role of its PLP cofactor, is under investigation. Many PLP-dependent transaminases have a negatively charged amino acid residue forming a salt-bridge with the pyridine nitrogen of its cofactor that promotes its protonation to stabilize the formation of a ketimine intermediate, which is subsequently hydrolyzed in the normal transaminase reaction pathway. However, alanine racemase has a positively charged arginine held rigidly in place by an extensive hydrogen bond network that may destabilize the ketimine intermediate, and make it too short-lived for a transaminase type of hydrolysis to occur. To test this hypothesis, we changed Glu-177 into a titratable, positively charged lysine (E177K). The crystal structure of this mutant shows that the positive charge of the newly introduced lysine side chain points away from the nitrogen of the cofactor, which may be due to electrostatic repulsions not being overcome by a hydrogen bond network such as found in alanine racemase. This mutation makes the active site more accessible, as exemplified by both biochemical and crystallographic data: CD measurements indicated a change in the microenvironment of the protein, some SH groups become more easily titratable, and at pH 9.0 the PMP peak appeared around 315 nm rather than at 330 nm. The ability of this mutant to convert L-alanine into D-alanine increased about 10-fold compared to wild-type and to about the same extent as found with other active site mutants. On the other hand, the specific activity of the E177K mutant decreased more than 1000-fold compared to wild-type. Furthermore, titration with L-alanine resulted in the appearance of an enzyme-substrate quinonoid intermediate absorbing around 500 nm, which is not observed with usual substrates or with the wild-type enzyme in the presence of L-alanine. The results overall indicate the importance of charged amino acid side chains relative to the coenzyme to maintain high catalytic efficiency.


Assuntos
Conformação Proteica , Fosfato de Piridoxal/metabolismo , Transaminases/química , Transaminases/metabolismo , Substituição de Aminoácidos , Sítios de Ligação , Domínio Catalítico , Dicroísmo Circular , Clonagem Molecular , Cristalografia por Raios X , D-Alanina Transaminase , Cinética , Modelos Moleculares , Fragmentos de Peptídeos/química , Mapeamento de Peptídeos , Mutação Puntual , Proteínas Recombinantes/química , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Transaminases/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa